AIM ImmunoTech Inc. SEC filings AIM

AIM ImmunoTech Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 6, 2013. Its latest annual report, Form ARS, was filed on Sep 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Nov 17, 2025 Sep 30, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q/A Amended quarterly report Aug 17, 2021 Jun 30, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
10-Q/A Amended quarterly report May 14, 2020 Mar 31, 2020
10-Q Quarterly report May 14, 2020 Mar 31, 2020
10-Q Quarterly report Nov 14, 2019 Sep 30, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
10-Q Quarterly report May 15, 2019 Mar 31, 2019
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
10-Q Quarterly report Aug 14, 2018 Jun 30, 2018
10-Q Quarterly report May 15, 2018 Mar 31, 2018
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
10-Q Quarterly report Aug 14, 2017 Jun 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
10-Q/A Amended quarterly report Jan 13, 2017 Sep 30, 2011
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
10-Q/A Amended quarterly report Aug 29, 2016 Mar 31, 2016
10-Q Quarterly report Aug 15, 2016 Jun 30, 2016
10-Q Quarterly report May 16, 2016 Mar 31, 2016
10-Q Quarterly report Nov 16, 2015 Sep 30, 2015
10-Q Quarterly report Aug 12, 2015 Jun 30, 2015
10-Q Quarterly report May 12, 2015 Mar 31, 2015
10-Q Quarterly report Nov 7, 2014 Sep 30, 2014
10-Q Quarterly report Aug 8, 2014 Jun 30, 2014
10-Q Quarterly report May 9, 2014 Mar 31, 2014

Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
AIM (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Ocala, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
946644
Former names
AIM ImmunoTech Inc. (until Nov 5, 2026); HEMISPHERX BIOPHARMA INC (until Aug 26, 2019)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.